Doliver Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Hold |
|
|||||
|
2025
Q2 | $2.46M | Buy |
|
|||||
|
2025
Q1 | $557K | Hold |
|
|||||
|
2024
Q4 | $559K | Sell |
|
|||||
|
2024
Q3 | $616K | Hold |
|
|||||
|
2024
Q2 | $501K | Hold |
|
|||||
|
2024
Q1 | $411K | Hold |
|
|||||
|
2023
Q4 | $485K | Hold |
|
|||||
|
2023
Q3 | $573K | Hold |
|
|||||
|
2023
Q2 | $570K | Hold |
|
|||||
|
2023
Q1 | $676K | Hold |
|
|||||
|
2022
Q4 | $930K | Hold |
|
|||||
|
2022
Q3 | $1.02M | Hold |
|
|||||
|
2022
Q2 | $857K | Hold |
|
|||||
|
2022
Q1 | $1.32M | Sell |
|
|||||
|
2021
Q4 | $1.52M | Hold |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|